A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS for children and adults living with Lennox–Gastaut syndrome (LGS).
Pascale V Guillot, at the University College London, looks toward improving the quality of life for those with Osteogenesis imperfecta, a chronic health condition called brittle bone disease.
Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.
The link between food insecurity and diabetes is stronger than previously thought - with people who are more likely to be hungry experiencing a higher rate of diabetes, ten years on.
Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
The World Health Organisation, in liaison with Ghana and Norway, announced a noncommunicable diseases strategy that aims to save 50 million people by 2030.
Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines
According to new results in the Journal of Alzheimer’s Disease, patients who start abusing alcohol in later life – after age 40 – maybe doing so due to underlying dementia
